Previous close | 484.93 |
Open | 483.50 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 483.50 - 493.10 |
52-week range | 308.40 - 600.90 |
Volume | |
Avg. volume | 103,234 |
Market cap | 36.285B |
Beta (5Y monthly) | 0.63 |
PE ratio (TTM) | 0.12 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Explore key insights from Acumen Pharmaceuticals' Q1 2024 earnings, focusing on their innovative Alzheimer's treatments and financial outlook.
Despite a net loss, MRVI showcases strategic expansions and robust partnerships, setting the stage for future growth.
Lonza Group ( VTX:LONN ) Full Year 2023 Results Key Financial Results Revenue: CHF6.72b (up 7.9% from FY 2022). Net...